Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer

JAMA

Volumn 281, Issue 24, 1999, Pages 2316-2320

  Weber, Thomas K ^a   Chin, Hyung Min ^b   Rodriguez Bigas, Miguel ^a   Keitz, Bernadette ^a   Gilligan, Rebecca ^c   O'Malley, Linda ^a   Urf, Edwin ^a   Diba, Nazli ^a   Pazik, James ^a   Petrelli, Nicholas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ISOLEUCINE; LEUCINE; NUCLEOTIDE; PHENYLALANINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; HUMAN; MALE; NEGRO; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033001537     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.24.2316     Document Type: Article

References (61)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
2. Boring CC Squires TS, Heath CW Jr. Cancer statistics for African-Americans. CA Cancer J Clin, 1992; 42:7-17.
3. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon career. Cancer. 1996;78:918-926.
4. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686-1693.
5. Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997;6:283-285.
6. Warthin AS. The further study of a cancer family. Cancer Res. 1925;9:279-286.
7. Lynch HT, Smyrk T, Watson P, et al. Hereditary colorectal cancer. Semin Oncol. 1991;18:337-366.
8. Vasen HF, Mecklin J-P, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer. Dis Colon Rectum. 1991; 34:424-425.
9. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260:810-812.
10. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet. 1993;5:279-282.
11. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75: 1027-1038.
12. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-1225.
13. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994;368:258-261.
14. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263:1625-1629.
15. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
16. Palombo F, Gallinari P, Iaccarino I, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science. 1995;268: 1912-1914.
17. Levinson G, Gutman GA. High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucleic Acids Res. 1987;15:5323-5338.
18. Prolla TA, Pang Q, Alani E, Kolodner RD, Liskay RM. MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science. 1994;265:1091-1093.
19. Liu B, Parsons RE, Hamilton SR. et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 1994;54:4590-4594.
20. Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet. 1995;56:1060-1066.
21. Tannergard P, Lipford JR, Kolodner R, Frodin JE, Nordenskjold M, Lindblom A. Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res. 1995;55:6092-6096.
22. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med. 1995; 332:839-847.
23. Nystrom-Lahti M, Wu Y, Moisio AL, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet. 1996;5:763-769.
24. Wijnen J, Khan PM, Vasen H, et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet. 1996;58:300-307.
25. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nat Med. 1996; 2:169-174.
26. Kohonen-Corish M, Ross VL, Doe WF, et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet. 1996;59:818-824.
27. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res. 1995;55:242-248.
28. Mauillon JL, Michel P, Limacher JM, et al. Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res. 1996;56:5728-5733.
29. Viel A, Genuardi M, Capozzi E, et al. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer. 1997;18:8-18.
30. Froggatt NJ, Joyce JA, Evans DG, et al. MSH2 sequence variations and inherited colorectal cancer susceptibility. Eur J Cancer. 1996;32A:178.
31. Tomlinson IP, Beck NE, Homfray T, Harocopos CJ, Bodmer WF. Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer. J Med Genet. 1997;34:39-42.
32. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med. 1998;339:511-518.
33. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
34. Weber T. Clinical surveillance recommendations adopted for HNPCC. Lancet. 1996;348:465.
35. Burke W, Peterson G, Lynch P, et al. Recommendations for the follow-up care of individuals with an inherited predisposition to cancer, I: hereditary nonpolyposis colon cancer. JAMA. 1997;277:915-919.
36. Purtilo DT, Geelhoed GW, Li FP, et al. Mucinous colon carcinoma in a black family. Cancer Genet Cytogenet 1987;24:11-15.
37. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenotnatous polyposis coli gene. Cell. 1991;66:589-600.
38. Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet. 1991;338:82-83.
39. Weber TK, Conlon W, Petrelli NJ, et al. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res. 1997;57: 3798-3803.
40. MSH2 & MLH1 Mutation Data Base of The International Collaborative Group on HNPCC. Available at: http://www.nfdht.nl/database/msh2-1.htm. Accessed April 2, 1999.
41. Rodriguez-Bigas MA, Lee PH, O'Malley L, et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum. 1996;39:649-653.
42. Han HJ, Maruyama M, Baba S, Park JG, Nakamura Y. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum Mol Genet. 1995;4:237-242.
43. Moisio AL, Sistonen P, Weissenbach J, de la Chapelle A, Peltomaki P. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet. 1996;59:1243-1251.
44. Nystrom-Lahti M, Kristo P, Nicolaides NC, et al. Founding mutations and alu-mediated recombination in hereditary colon cancer. Nat Med. 1995;1: 1203-1206.
45. Wahlberg SS, Nystrom-Lahti M, Kane MF, Kolodner RD, Peltomaki P, Lindblom A. Low frequency of hMSH2 mutations in Swedish HNPCC families, Int J Cancer. 1997;74:134-137.
46. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-272.
47. Lewis CM, Neuhausen SL, Daley D, et al. Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res. 1996;56:1382-1388.
48. Yamamoto H, Sawai H, Weber TK, Rodriguez-Bigas MA, Perucho M. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 1998;58:997-1003.
49. Pang Q, Prolla TA, Liskay RM. Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations. Mol Cell Biol. 1997;17: 4465-4473.
50. White RL. Excess risk of colon cancer associated with a polymorphism of the APC gene? Cancer Res. 1998;58:4038-4039.
51. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
52. Beck NE, Tomlinson IP, Homfray T, et al. Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. Hum Genet. 1997;99:219-224.
53. Fan E, Levin DB, Glickman BW, Logan DM. Limitations in the use of SSCP analysis. Mutat Res. 1993; 288:85-92.
54. Glavac D, Dean M. Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat. 1993;2:404-414.
55. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA. 1998; 279:922-929.
56. Xia L, Shen W, Ritacca F, et al. A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res. 1996;56:2289-2292.
57. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110:682-687.
58. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83:259-266.
59. Percesepe A, Benatti P, Roncucci L, et al. Survival analysis in families affected by hereditary nonpolyposis colorectal cancer. Int J Cancer. 1997;71: 373-376.
60. Peltomaki P. Microsatellite instability as an indicator of hereditary susceptibility to colon cancer. Gastroenterology. 1995;109:2031-2033.
61. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1408.